Clinical Trial: Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: PhaseⅢ Study of A Multicenter, Randomized, Double-blind, Active-controlled to Evaluate of Efficacy /Safety as H. Pylori Eradication Effect Between Ilaprazole/Pantoprazole

Brief Summary: The purpose of this study is to evaluate of efficacy and safety as H.pylori eradiation effect between Ilaprazole and Pantoprazole triple therapy for 7 days treatment in Gastric and/or Duodenal ulcer patients with H.pylori positive infection.

Detailed Summary: This study is to evaluate of efficacy and safety as H.pylori eradiation effect between Ilaprazole and Pantoprazole triple therapy for 7 days treatment in Gastric and/or Duodenal ulcer patients with H.pylori positive infection.
Sponsor: Il-Yang Pharm. Co., Ltd.

Current Primary Outcome: the rate of H.pylori eradication [ Time Frame: participants will be followed at 7 weeks (visit 4) ]

Original Primary Outcome: Same as current

Current Secondary Outcome: the rate of Gastric and/or Duodenal ulcer curation [ Time Frame: participants will be followed at 7 weeks (visit 4) ]

Original Secondary Outcome: Same as current

Information By: Il-Yang Pharm. Co., Ltd.

Dates:
Date Received: March 5, 2014
Date Started: December 2012
Date Completion:
Last Updated: June 2, 2014
Last Verified: June 2014